Home/ Supplements/ Vitamin A/ PNV Tabs 29-1

PNV Tabs 29-1

product on market Tablet or Pill Virtus Pharmaceuticals Safety: 96/100
96/100

This product looks safe

  • Folic Acid: 500mg is 500.0× the Tolerable Upper Intake Level (1.0mg)
  • Folic Acid: 600mg is 600.0× the Tolerable Upper Intake Level (1.0mg)
  • 74% of ingredients have research evidence
D Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

The profile contains essential vitamins A, C, D, E, and thiamine, which support immune function and cellular health. There is strong research evidence for the biological roles of these micronutrients in human health. The formulation maintains a high safety score, though overall evidence coverage for the specific blend is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Folic Acid: 500mg is 500.0× the Tolerable Upper Intake Level (1.0mg)

Folic Acid: 600mg is 600.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for PNV Tabs 29-1
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Multi-Vitamin and Mineral (MVM)
Product Type
74%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
600 mcg RAE (46% DV)
Vitamin C
120 mg (100% DV)
10 mcg (67% DV)
Within RDA (0.7× RDA) 608 studies (A:16, B:251)
20 mg (105% DV)
1.3× RDA — within safe limits 179 studies (A:3, B:90)
3 mg (214% DV)
2.5× RDA — within safe limits 76 studies (A:0, B:33)
3 mg (188% DV)
2.3× RDA — within safe limits 13 studies (A:0, B:1)
20 mg NE (111% DV)
1.4× RDA — within safe limits 196 studies (A:5, B:63)
3 mg (150% DV)
2.3× RDA — within safe limits 114 studies (A:3, B:35)
500 mcg DFE (83% DV)
Exceeds UL by 500.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
600 mcg DFE (100% DV)
Exceeds UL by 600.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
8 mcg (286% DV)
3.3× RDA — above typical dose 139 studies (A:1, B:44)
30 mcg (86% DV)
Within RDA (1.0× RDA) 27 studies (A:0, B:11)
7 mg (100% DV)
1.4× RDA — within safe limits 2 studies — no high-quality reviews
Calcium
200 mg (15% DV)
Iron
29 mg (161% DV)
150 mcg (52% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
100 mg (25% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
15 mg (115% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
3 mg (231% DV)
3.3× RDA — above typical dose (UL: 10 mg) 37 studies (A:0, B:11)

Other Ingredients

Microcrystalline Cellulose Stearic Acid Coating Croscarmellose Sodium Silicon Dioxide Magnesium Stearate
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions for use: 1 tablet daily with or without food or as prescribed by a licensed medical practitioner, regardless of lactation status.

Warnings & Precautions

May contain allergens: See professional information.

Description: PNV Tabs 29-1 is an oral prescription dietary supplement and should be administered under the supervision of a licensed medical practitioner.

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Caution: High levels of folic acid may hide signs of B-12 deficiency, such as pernicious anemia. See professional information. Side effects: See professional information.

Keep out of reach of children.

Formulation Notes

Prenatal/Postnatal

Prescription Folic Acid-containing

Additional Information

69543-267-90

Rx Made in the USA

The % Daily Value tells you how much a nutrient in a serving of food contributes to a daily diet. 2,000 calories a day is used for general nutrition advice.

Storage: Store at controlled room temperature 15(0) to 30(0)C (59(0) to 86(0)F). Protect from light and moisture. Dispense in a tight, light-resistant container. Notice: Contact with moisture may produce surface discoloration or erosion.

Call you licensed medical practitioner about side effects. You may report side effects to Virtus at 1-888-848-3593.

Rev. 1/2017

Metadata

Product Details

UPC / SKU3 69543 26790 6
DSLD Entry Date2018-08-31
Product TypeMulti-Vitamin and Mineral (MVM)
FormTablet or Pill
BrandVirtus Pharmaceuticals
DSLD ID180567
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

Prenatal/Postnatal
Redmont Pharmaceuticals · Tablet or Pill
100
ActiveMV
dotFIT · Tablet or Pill
100
X7 - Care
OL Olympian Labs · Tablet or Pill
100
Children's Chewable Vite
Rugby · Tablet or Pill
100
Zoo Friends with Xtra C
21st Century Zoo Friends · Tablet or Pill
100
View all Vitamin A products →
Vitamin A research Best Vitamin A All Vitamin A products More from Virtus Pharmaceuticals View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.